SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of BioSpecifics Technologies Corp. - BSTC
NEW YORK, Oct. 20, 2020 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating BioSpecifics Technologies Corporation. ("BioSpecifics" or the "Company") (BSTC) relating to its proposed acquisition by Endo International PLC. Under the terms of the agreement, BioSpecifics shareholders will receive $88.50 per share in cash.
The investigation focuses on whether BioSpecifics Technologies Corp. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process and 2) whether and by how much this proposed transaction undervalues the Company.
Click here for more information: https://www.monteverdelaw.com/case/biospecifics-technologies-corp. It is free and there is no cost or obligation to you.
About Monteverde & Associates PC
If you own common stock in BioSpecifics Technologies Corp. and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at firstname.lastname@example.org or by telephone at (212) 971-1341.
Attorney Advertising. (C) 2020 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-monteverde--associates-pc-announces-an-investigation-of-biospecifics-technologies-corp---bstc-301157070.html
SOURCE Monteverde & Associates PC
Company Codes: NASDAQ-NMS:BSTC